Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 4, 2022, Jerald Korn, the General Counsel and Chief Operating Officer
of Kaleido Biosciences, Inc. (the "Company"), submitted notice to the Company of
his resignation, effective March 18, 2022, to pursue another opportunity. The
Company will be entering into a consulting agreement with Mr. Korn pursuant to
which Mr. Korn will provide general administrative and other corporate services
to the Company through April 30, 2022. The Company thanks Mr. Korn for his
contributions.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses